![Shipra Gandhi: How a novel strategy can modulate the chemokine milieu in the TME](https://oncodaily.com/pub/uploads/2023/11/111111-1-e1700682536159.jpeg)
Photo of Shipra Gandhi from medicine.buffalo.edu
Nov 22, 2023, 16:06
Shipra Gandhi: How a novel strategy can modulate the chemokine milieu in the TME
Shipra Gandhi, Translational Researcher at Roswell Park Comprehensive Cancer Center, shared a post by Journal for ImmunoTherapy of Cancer on X/Twitter, adding:
”We are excited to share our findings from a clinical trial in TNBC showing how a novel strategy can modulate the chemokine milieu in the TME.”
Quoting Journal for ImmunoTherapy of Cancer‘s post:
”New JITC article: Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor micro environments for selective CTL influx.”
For the article click here.
Source: Shipra Gandhi/Twitter and Journal for ImmunoTherapy of Cancer/Twitter
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 10, 2024, 16:09
Sep 10, 2024, 16:04
Sep 10, 2024, 15:57
Sep 10, 2024, 15:46
Sep 10, 2024, 15:41
Sep 10, 2024, 14:54